CytoBead® Technology Fast and simplified immunofluorescence analysis

CytoBead® Technology is the next generation of immunofluorescence testing. Through the combination of natural cells or tissues with protein coated microparticles (microbeads) in one well, simultaneous screening tests at the cellular level and testing at the biochemical level for the specific differentiation of antibodies is achieved. At the end of this laboratory procedure, which takes less than two hours, both results are available.

Using conventional methods, the qualitative evaluation (screening) was carried out with a fluorescence microscope, whereby in the second step (differentiation) the determination of antibody specificity and content was performed with separate ELISA assays. With CytoBead® Technology, this is achieved in a single test. This effectively saves time, materials and money.

GA Generic Assays is represented again as an exhibitor in Düsseldorf this year.Meet us at our booth no. F52, Hall 3.We look forward to you!Further Information: http://www.medica-tradefair.com/
From July 27 until August 2, 2018 the 70th AACC Annual Scientific Meeting & Clinical Lab Expo will be taking place in Chicago (Illinois).The AACC is the largest global scientific conference and tradeshow in the field of laboratory medicine.We - the company GA Generic Assays GmbH - develop and...
continue to produce RIAs for diabetes diagnostics and provide interested customers ...

Our new company presentation 2018